Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.

Harder, Thomas; Koch, Judith; Vygen-Bonnet, Sabine; Külper-Schiek, Wiebe; Pilic, Antonia; Reda, Sarah; Scholz, Stefan; Wichmann, Ole

Harder, Thomas; Koch, Judith; Vygen-Bonnet, Sabine; Külper-Schiek, Wiebe; Pilic, Antonia; Reda, Sarah; Scholz, Stefan; Wichmann, Ole.

Afiliación

Harder T; Robert Koch Institute, Berlin, Germany.
Koch J; Robert Koch Institute, Berlin, Germany.
Vygen-Bonnet S; Robert Koch Institute, Berlin, Germany.
Külper-Schiek W; Robert Koch Institute, Berlin, Germany.
Pilic A; Robert Koch Institute, Berlin, Germany.
Reda S; Robert Koch Institute, Berlin, Germany.
Scholz S; Robert Koch Institute, Berlin, Germany.
Wichmann O; Robert Koch Institute, Berlin, Germany.

Euro Surveill ; 26(28)2021 07.

Article en En | MEDLINE | ID: mdl-34269175

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Infecciones Asintomáticas; Humanos; SARS-CoV-2

Palabras clave

COVID-19; SARS-CoV-2; systematic review; vaccination; vaccine effectiveness

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google